ACM
CRMD icon

Antonetti Capital Management’s CorMedix CRMD Stock Holding History

Antonetti Capital Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$1K – 344
2022
Q3 		$1K Hold
200
– – ﹤0.01% 305
2022
Q2 		$1K Hold
200
– – ﹤0.01% 310
2022
Q1 		$1K Hold
200
– – ﹤0.01% 332
2021
Q4 		$1K Hold
200
– – ﹤0.01% 384
2021
Q3 		$1K Buy
+200
New +$1.17K ﹤0.01% 401

Other funds holding CRMD

Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SC
Spinnaker Capital Boston, Massachusetts $1.08M AUM 45.28% 1-Year Est. Return

Antonetti Capital Management's CRMD Position: Q4 2022 in Review

Antonetti Capital Management sold out of CorMedix (CRMD) in Q4 2022, closing a stake of 200 shares — an estimated $1K sold.

Antonetti Capital Management first reported a position in CRMD in Q3 2021 and held it in 5 quarters. The position peaked at $1K in Q3 2022. 65 funds tracked by Wall St. Rank hold CRMD as of Q4 2022.

  • Antonetti Capital Management reported no remaining CorMedix position as of Q4 2022 after selling out during the quarter.
  • Antonetti Capital Management sold 200 CorMedix shares in Q4 2022, an estimated $1K.
  • Antonetti Capital Management first reported a position in CorMedix in Q3 2021 and held it in 5 quarters.
  • Antonetti Capital Management's CorMedix position peaked at $1K in Q3 2022.
  • 65 funds tracked by Wall St. Rank held CorMedix as of Q4 2022.

Based on Antonetti Capital Management's 13F filing for Q4 2022, filed 1 Feb 2023.